Integra LifeSciences Holdings Corporation (NASDAQ:IART) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 3.38%.
Integra LifeSciences Holdings Corporation Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 18.92% to $0.60 in the quarter versus EPS of $0.74 in the year-earlier quarter.
Revenue: Decreased 2.22% to $205.5 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Integra LifeSciences Holdings Corporation reported adjusted EPS income of $0.60 per share. By that measure, the company beat the mean analyst estimate of $0.55. It missed the average revenue estimate of $207.3 million.
Quoting Management: “We are pleased to deliver second quarter revenues within our guidance range,” said Peter Arduini, Integra’s President and Chief Executive Officer. “Our supply chain and operations teams achieved our regenerative product supply objectives, and we managed overall expenses well in the quarter.”
Key Stats (on next page)…
Revenue increased 4.5% from $196.65 million in the previous quarter. EPS increased 53.85% from $0.39 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.76 to a profit $0.72. For the current year, the average estimate has moved down from a profit of $2.71 to a profit of $2.52 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)